CVrg Full Corporate Service offers direct access to our experts & resources in 12 disease areas.
|CVrg Market Strategies||
Each of CVrg’s cutting-edge market analysis reports provides a highly granular assessment of new product development, emerging trends, unmet needs, epidemiology, current treatment and market forecasts. KOL comments, SWOTs, trial tracking, launch estimations and target patient populations are included for products ≥Ph 2 along with regional coverage of USA, EU5, and Japan. Updated quarterly and enhanced by expert analysis, this is a “go to” report that’s evergreen throughout the year.
CVrg continuously monitors how new scientific, clinical, regulatory and market developments are changing the commercial potential of cardio-metabolic assets. This monthly report updates to alert and fully inform our subscribers about what is happening in the marketplace and how it might affect their products.
|CVrg KOL Insights||
CVrg experts conduct primary research with KOLs in several disease areas using their critical eyes to evaluate emerging trends, pipeline products and implications for the field. Clients may review and make suggestions to our discussion guides and receive detailed reports and presentations focused on answering the most pressing issues they face today. Not conducted in all areas.
CVrg keeps abreast of cutting edge clinical data by attending cardio-metabolic congresses such as ACC, ADA, ESC, AHA, ASN, EASD, and AASLD. Our experts carefully analyze the new data presented as well as how its received by the other attendees, we then deliver incisive, presentation-style reports informing subscribers about what’s new, what’s important, and why.
answers to your ad-hoc inquiries
CVrg is uniquely positioned to deliver quick, thorough and reliable answers to non-proprietary questions in the cardio-metabolic drug markets. We put our best methodologies and efforts behind each inquiry so clients receive the most accurate insight possible within a given timeframe.